A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep

REFERENCES

• Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Jr., Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ, Fibrosis AEJACoIP: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.
   PubMed Web of Science ®Google Scholar
• Günther A, Korfei M, Mahavadi P, von der Beck D, Ruppert C, Markart P: Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis. Eur Respir Rev. 2012;21(124):152–160.
   PubMedGoogle Scholar
• King T, Schwarz M, Brown K, Tooze J, Colby T, Waldron J, Flint A, Thurlbeck W, Cherniack R: Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001;164(6): 1025–1032.
   PubMed Web of Science ®Google Scholar
• Sandbo N: Mechanisms of fibrosis in IPF. In: Keith C, Meyer SDN, eds. Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide Series Respiratory Medicine. Vol. 9. New York: Humana Press; 2014:164–205.
   Google Scholar
• Talmadge TE, Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083–2092.
   PubMed Web of Science ®Google Scholar
• Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR, Investigators IT: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–2082.
   PubMed Web of Science ®Google Scholar
• Moore B, Hogaboam C: Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294(2):152–160.
   PubMed Web of Science ®Google Scholar
• Moore B, Lawson W, Oury T, Sisson T, Raghavendran K, Hogaboam C: Animal models of fibrotic lung disease. Am J Respir Cell Mol Biol. 2013;49(2):167–179.
   PubMed Web of Science ®Google Scholar
• Moeller A, Ask K, Warburton D, Gauldie J, Kolb M: The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Intl J Biochem Cell Biol. 2008;40(3):362–382.
   PubMed Web of Science ®Google Scholar
• Fabrizio L, Paolo S, Stefania C, Luca R: The big clinical trials in idiopathic pulmonary fibrosis. Curr Opin Pulmon Med. 2012;18:428–432
   PubMed Web of Science ®Google Scholar
• Bischof R, Snibson K, Shaw R, Meeusen E: Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite. Clin Exp Allergy. 2003;33(3):367–375.
   PubMed Web of Science ®Google Scholar
• Snibson KJ, Bischof RJ, Slocombe RF, Meeusen EN: Airway remodelling and inflammation in sheep lungs after chronic airway challenge with house dust mite. Clin Exp Allergy. 2005;35(2):146–152.
   PubMed Web of Science ®Google Scholar
• Van der Velden J, Barker D, Barcham G, Koumoundouros E, Snibson K: Assessment of peripheral airway function following chronic allergen challenge in a sheep model of asthma. PloS one. 2011;6(12):e28740, 1–6
   Google Scholar
• Collie DD, Baker A, Mauchline S, Porteous D, Mc LG: Ovine bronchoalveolar lavage cellularity: reproducibility and the effect of multiple repeated lavage. Res Vet Sci. 1999;67(2): 137–140.
   PubMed Web of Science ®Google Scholar
• Collie DD, McLean N, Sallenave JM, Baker A, Blundell R, Milne E, Rhind S, Woodall C: Local lung responses following endobronchial elastase and lipopolysaccharide instillation in sheep. Int J Chron Obstruct Pulmon Dis. 2006;1(2):189–199.
   PubMedGoogle Scholar
• Balazs G, Noma S, Khan A, Eacobacci T, Herman PG: Bleomycin-induced fibrosis in pigs: evaluation with CT. Radiology. 1994;191(1):269–272.
   PubMed Web of Science ®Google Scholar
• Bray B, Osman M, Ashtyani H, Mandl I, Turino G: The fibronectin content of canine lungs is increased in bleomycin-induced fibrosis. Exp Mol Pathol. 1986;44(3):353–363.
   PubMed Web of Science ®Google Scholar
• Berzon D, Menkes H, Dannenberg A, Gertner A, Terry P, Plump D, Bromberger-Barnea B: Interstitial fibrosis and collateral ventilation. J Appl Physiol. 1986;61(1):300–303.
   PubMed Web of Science ®Google Scholar
• Michel RP, Hakim TS, Freeman CR: Distribution of pulmonary vascular resistance in experimental fibrosis. J Appl Physiol. 1988;65(3):1180–1190.
   PubMed Web of Science ®Google Scholar
• Degryse A, Tanjore H, Xu X, Polosukhin V, Jones B, McMahon F, Gleaves L, Blackwell T, Lawson W: Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010;299(4): 442–452.
   PubMed Web of Science ®Google Scholar
• Tsai LW, Hoffman AM, Mazan MR, Ingenito EP: Bronchoscopic measurement of collateral ventilation in a sheep model of emphysema. Respiration. 2007;74(5):565–571.
   PubMed Web of Science ®Google Scholar
• Cetti E, Moore A, Geddes D: Collateral ventilation. Thorax. 2006;61(5):371–373.
   PubMed Web of Science ®Google Scholar
• Cherniack RM, Colby TV, Flint A, Thurlbeck WM, Waldron J, Ackerson L, King TEJr: Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1991;144(4):892–900.
   PubMed Web of Science ®Google Scholar
• Izbicki G, Segel M, Christensen T, Conner M, Breuer R: Time course of bleomycin-induced lung fibrosis. Intl J Exp Pathol. 2002;83(3):111–119.
   PubMed Web of Science ®Google Scholar
• Atik A, Sozo F, Orgeig S, Suri L, Hanita T, Harding R, De Matteo R: Long-term pulmonary effects of intrauterine exposure to endotoxin following preterm birth in sheep. Reprod Sci. 2012;19(12):1352–1364.
   PubMed Web of Science ®Google Scholar
• Maritz G, Probyn M, De Matteo R, Snibson K, Harding R: Lung parenchyma at maturity is influenced by postnatal growth but not by moderate preterm birth in sheep. Neonatology. 2008;93(1):28–35.
   PubMed Web of Science ®Google Scholar
• Van der Velden J, Barker D, Barcham G, Koumoundouros E, Snibson K: Increased vascular density is a persistent feature of airway remodeling in a sheep model of chronic asthma. Exp Lung Res. 2012;38(6):307–315.
   PubMed Web of Science ®Google Scholar
• Van Der Velden J, Sum G, Barker D, Koumoundouros E, Barcham G, Wulff H, Castle N, Bradding P, Snibson K: KCa3.1 channel-blockade attenuates airway pathophysiology in a sheep model of chronic asthma. PloS one. 2013;8(6):e66886, 1–7.
   PubMed Web of Science ®Google Scholar
• Samuel CS: Determination of collagen content, concentration, and sub-types in kidney tissue. Methods Mol Biol. 2009;466:223–235.
   PubMedGoogle Scholar
• Moodley Y, Vaghjiani V, Chan J, Baltic S, Ryan M, Tchongue J, Samuel CS, Murthi P, Parolini O, Manuelpillai U: Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PloS One. 2013;8(8):e69299, 1–9
   PubMed Web of Science ®Google Scholar
• Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White D, Hartenstein V, Eliceiri K, Tomancak P, Cardona A: Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–682.
   PubMed Web of Science ®Google Scholar
• Abraham T, Hogg J: Extracellular matrix remodeling of lung alveolar walls in three dimensional space identified using second harmonic generation and multiphoton excitation fluorescence. J Struct Biol. 2010;171(2):189–196.
   PubMed Web of Science ®Google Scholar
• Pena A-M, Fabre A, Débarre D, Marchal-Somme J, Crestani B, Martin J-L, Beaurepaire E, Schanne-Klein M-C: Three-dimensional investigation and scoring of extracellular matrix remodeling during lung fibrosis using multiphoton microscopy. Microsc Res Tech. 2007;70(2):162–170.
   PubMed Web of Science ®Google Scholar
• Bouljihad M, Leipold HW: An ultrastructural study of pulmonary bronchiolar and alveolar epithelium in sheep. J Vet Med. 1994;41(8):573–586.
   Google Scholar
• Mercer R, Russell M, Crapo J: Alveolar septal structure in different species. J Appl Physiol. 1994;77(3):1060–1066.
   PubMed Web of Science ®Google Scholar
• Maritz G, Cock M, Louey S, Suzuki K, Harding R: Fetal growth restriction has long-term effects on postnatal lung structure in sheep. Pediatr Res. 2004;55(2):287–295.
   PubMed Web of Science ®Google Scholar
• Haber PS, Colebatch HJ, Ng CK, Greaves IA: Alveolar size as a determinant of pulmonary distensibility in mammalian lungs. J Appl Physiol Respir Environ Exerc Physiol. 1983;54(3):837–845.
   PubMed Web of Science ®Google Scholar
• Mercer R, Crapo J: Spatial distribution of collagen and elastin fibers in the lungs. J Appl Physiol. 1990;69(2):756–765.
   PubMed Web of Science ®Google Scholar
• Suki B, Ito S, Stamenovic D, Lutchen KR, Ingenito EP: Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces. J Appl Physiol. 2005;98(5):1892–1899.
   PubMed Web of Science ®Google Scholar
• Suki B, Bates J: Extracellular matrix mechanics in lung parenchymal diseases. Respir Physiol Neurobiol. 2008;163 (1–3):33–43.
   PubMed Web of Science ®Google Scholar
• Enomoto N, Suda T, Kono M, Kaida Y, Hashimoto D, Fujisawa T, Inui N, Nakamura Y, Imokawa S, Funai K, Chida K: Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis. Respir Med. 2013;107(10):1608–1616.
   PubMed Web of Science ®Google Scholar
• Faffe D, Zin W. Lung parenchymal mechanics in health and disease. Physiol Rev. 2009;89(3):759–775.
   PubMed Web of Science ®Google Scholar
• Leslie KO: Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. Arch Pathol Lab Med. 2012;136(6):591–600.
   PubMed Web of Science ®Google Scholar
• Meyer KC, Nathan SD: Idiopathic pulmonary fibrosis: A Comprehensive Clinical Guide. Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide. New York: Humana Press; 2014.
   Google Scholar
• Lazo J, Hoyt D, Sebti S, Pitt B: Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol Therapeut. 1990;47(3):347–358.
   PubMed Web of Science ®Google Scholar
• Cherniack RM, Colby TV, Flint A, Thurlbeck WM, Waldron JA, Jr., Ackerson L, Schwarz MI, King TE, Jr: Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1995;151(4):1180–1188.
   PubMed Web of Science ®Google Scholar
• Chung MP, Monick MM, Hamzeh NY, Butler NS, Powers LS, Hunninghake GW: Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol. 2003;29(3 Pt 1):375–380.
   PubMed Web of Science ®Google Scholar
• Polosukhin V, Degryse A, Newcomb D, Jones B, Ware L, Lee J, Loyd J, Blackwell T, Lawson W: Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice. Exp Lung Res. 2012;38(3):135–146.
   PubMed Web of Science ®Google Scholar
• Shen A, Haslett C, Feldsien D, Henson P, Cherniack R: The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am Rev Respir Dis. 1988;137(3):564–571.
   PubMed Web of Science ®Google Scholar
• Chaudhary N, Schnapp A, Park J: Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173(7):769–776.
   PubMed Web of Science ®Google Scholar
• Walters D, Kleeberger S: Mouse models of bleomycin-induced pulmonary fibrosis. Curr Protoc Pharmacol. 2008; Chap 5, Sect 46:1–17.
   PubMedGoogle Scholar
• Tatler A, Jenkins G: TGF-β activation and lung fibrosis. Proc Am Thoracic Soc. 2012;9(3):130–136.
   PubMedGoogle Scholar
• Lomas NJ, Watts KL, Akram KM, Forsyth NR, Spiteri MA: Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers. Intl J Clin Exp Pathol. 2012;5(1):58–71.
   PubMedGoogle Scholar
• Khalil N, O'Connor R, Flanders K, Unruh H: TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol. 1996;14(2):131–138.
   PubMed Web of Science ®Google Scholar
• Coker R, Laurent G, Shahzeidi S, Lympany P, du Bois R, Jeffery P, McAnulty R: Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol. 1997;150(3):981–991.
   PubMed Web of Science ®Google Scholar
• Broekelmann T, Limper A, Colby T, McDonald J: Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA. 1991;88(15):6642–6646.
   PubMed Web of Science ®Google Scholar
• Cosgrove G, Brown K, Schiemann W, Serls A, Parr J, Geraci M, Schwarz M, Cool C, Worthen G: Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med. 2004;170(3):242–251.
   PubMed Web of Science ®Google Scholar
• Vij R, Noth I: Peripheral blood biomarkers in idiopathic pulmonary fibrosis. Transl Res. 2012;159(4):218–227.
   PubMed Web of Science ®Google Scholar
• Parra E, Teodoro W, Velosa AP, de Oliveira C, Yoshinari N, Capelozzi V: Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia. J Histochem Cytochem. 2006;54(12):1315–1325.
   PubMed Web of Science ®Google Scholar
• Hay E: Cell Biology of Extracellular Matrix. 1991. Berlin: Springer Science and Business Media.
   Google Scholar
• Chen W-L, Hu P-S, Ghazaryan A, Chen S-J, Tsai T-H, Dong C-Y: Quantitative analysis of multiphoton excitation autofluorescence and second harmonic generation imaging for medical diagnosis. Comput Med Imag Graphics. 2012;36(7):519–526.
   PubMed Web of Science ®Google Scholar
• Ley B, Collard H, King T: Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(4):431–440.
   PubMed Web of Science ®Google Scholar
• Collard H, King T, Bartelson B: Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168(5):538–542.
   PubMed Web of Science ®Google Scholar
• Ley B, Ryerson C, Vittinghoff E, Ryu J, Tomassetti S, Lee J, Poletti V, Buccioli M, Elicker B, Jones K, King T, Collard H: A multidimensional index and staging system for idiopathic pulmonary fibrosis. Annls Intern Med. 2012;156(10):684–691.
   PubMed Web of Science ®Google Scholar
• du Bois R, Nathan S, Richeldi L, Schwarz M, Noble P: Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials. Am J Respir Crit Care Med. 2012;186(8):712–715.
   PubMed Web of Science ®Google Scholar
• Bachofen H, Scherrer M: Lung tissue resistance in diffuse interstitial pulmonary fibrosis. J Clin Invest. 1967;46(1):133–140.
   PubMed Web of Science ®Google Scholar
• Fulmer J, Roberts W, von Gal E, Crystal R: Morphologic–physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest. 1979;63(4):665–676.
   PubMed Web of Science ®Google Scholar
• Fulmer J, Roberts W: Small airways and interstitial pulmonary disease. Chest. 1980;77(4):470–472.
   PubMed Web of Science ®Google Scholar
• Figueira de Mello GC, Ribeiro Carvalho CR, Adib Kairalla R, Nascimento Saldiva PH, Fernezlian S, Ferraz Silva LF, Dolhnikoff M, Mauad T. Small airway remodeling in idiopathic interstitial pneumonias: a pathological study. Respiration. 2010;79(4):322–332.
   PubMed Web of Science ®Google Scholar
• Fulmer J, Roberts W, von Gal E, Grystal R: Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. J Clin Invest. 1977;60(3):595–610.
   PubMed Web of Science ®Google Scholar
• Verbeken E, Cauberghs M, Lauweryns J, Van de Woestijne K: Structure and function in fibrosing alveolitis. J Appl Physiol. 1994;76(2):731–742.
   PubMed Web of Science ®Google Scholar
• Ostrow D, Cherniack RM: Resistance to airflow in patients with diffuse interstitial lung disease. Am Rev Respir Dis. 1973;108(2):205–210.
   PubMed Web of Science ®Google Scholar
• Schofield NC, Davies RJ, Cameron IR, Green M: Small airways in fibrosing alveolitis. Am Rev Respir Dis. 1976;113(6):729–735.
   PubMed Web of Science ®Google Scholar